Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

Clinical trial NCT01555138 · COMPLETED

Trial details

NCT number: NCT01555138
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2012-02-01
Primary completion: 2014-02-01
Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.